Thus, this study aims to investigate, through both in vivo and in vitro experiments, whether PMS can effectively mitigate ferroptosis in pancreatic beta cells in T2DM by activating the xCT/GPX4 pathway, offering a potential novel therapeutic approach for T2DM treatment. This evidence concerns the gene SLC7A11 and type 2 diabetes mellitus.